The Drug Enforcement Administration has issued a final rule to conform its regulations to the provision of the Anabolic Steroid Control Act of 2004. Effective Jan. 20, 2005, the act amended the Controlled Substances Act (CSA) and replaced the existing definition of anabolic steroid with a new one. This new definition altered the basis for all future administrative scheduling actions relating to the control of anabolic steroids as Schedule III controlled substances by eliminating the requirement to prove muscle growth. Additionally, the act lists 59 specific substances as being anabolic steroids. The rule will become effective on Jan. 17.
Mental Health and CBD: What's the Latest Info
October 27th 2022Drug Topics® is joined by Dr. Alex Capano, Chief Science Officer at Ananda Professional to discuss what CBD is used for mental health, where research should go next, and how to ensure that patients are getting effective CBD products.
Promoting Health Equity and Achieving Pharmacoequity to Ensure Medication Access for All
March 27th 2023Speakers at the 2023 virtual Value-Based Insurance Design Summit discussed government programs and company initiatives to advance health equity, as well as the role of research and advocacy to achieve pharmacoequity.
2 Clarke Drive
Cranbury, NJ 08512